Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
t4BbSw8FNyRPWP0k
